News

Agios Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States. Its lead product includes PYRUKYND (mitapivat ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Servier looks like it could bring a second IDH inhibitor from its 2021 takeover of Agios’ oncology business to market, after reporting positive results in a phase 3 brain cancer trial.
His Eminence Archbishop Nikitas of the Greek Orthodox Achdiocese of Thyateira and Great Britain and Metropolitan Alexios of Atlanta. After a procession from the Cathedral to the bayou, about 60 ...
Visit a quote page and your recently viewed tickers will be displayed here.
Agios Pharmaceuticals, Inc. (AGIO) Follow Add holdings Get top stock picks 35.50 +0.81 (+2.33%) At close: June 18 at 4:00:02 PM EDT Get top stock picks Conversations Community Insights Related Tickers ...
Age: 38 Sex: F Race: B Height: 506 Weight: 200 ...
The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.